Understanding how FUS protein behaves in neurodegenerative diseases like ALS
Residue-by-residue details of FUS protein phase separation and aggregation
This study is looking at how changes in the FUS protein, which is important for conditions like ALS and frontotemporal dementia, can cause it to clump together, and by using special imaging techniques, researchers hope to better understand this process to help create new treatments for these diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11068623 on NIH RePORTER |
What this research studies
This research investigates the behavior of the FUS protein, which is linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The study focuses on how mutations in the FUS protein can lead to its aggregation, which is a key feature of these diseases. By using advanced imaging techniques, researchers aim to visualize the changes in FUS protein structure and understand the mechanisms behind its transition from a liquid-like state to a solid form. This knowledge could help in developing targeted therapies for ALS and related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis or frontotemporal dementia.
Not a fit: Patients with neurodegenerative diseases not related to FUS protein aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating ALS and improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Fawzi, Nicolas Lux — Brown University
- Study coordinator: Fawzi, Nicolas Lux
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.